A B.C. Supreme Court justice has ruled that a class-action lawsuit meant to represent all adults in the province whose rights ...

Moderna, Inc. (NASDAQ:MRNA) today announced that it had voluntarily withdrawn the pending Biologics License Application (BLA) seeking approval for its COVID-19 and Influenza combination vaccine for ...

Co-Diagnostics withdrew its 510(k) application for its COVID-19 test to submit an enhanced version addressing shelf-life stability concerns. The new submission will incorporate platform improvements, ...

The enrollment period for Access Health CT begins at midnight on November 1, but the CEO is suggesting you defer taking any action. “In case Congress extends the enhanced subsidies,” CEO James Michel ...

(Reuters) -Moderna said on Friday it has filed a marketing application for the review of its updated COVID-19 vaccine with the U.S. Food and Drug Administration. The company said the submission for ...

Amid a period of great upheaval at the agency, the FDA has missed its deadline to decide on approval for Novavax’s COVID-19 shot. Novavax was expecting to hear back from the FDA about a full, ...